Skip to main content

interstitial lung disease Archives

Gut microbiota and lung fibrosis

Feb. 6, 2023—Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.

Read more


Progression of inflammatory lung disease analyzed

Apr. 2, 2020—A Vanderbilt University Medical Center interim analysis shows that there appears to be a considerable length of time before a subset of people develop inflammatory, scarring lung diseases where there is radiologically detectable evidence they will develop lung disease.

Read more


Watkins lecturer reminds that medicine is all about caring

Oct. 17, 2013—It's all about the patient. That's the message Talmadge King Jr., M.D., the Julius R. Krevans Distinguished Professor of Internal Medicine and chair of the Department of Medicine at the University of California, San Francisco (UCSF), shared with students, physicians, administrators and researchers during Wednesday’s Levi Watkins Jr., M.D., Lecture on Diversity in Medical Education.

Read more


Study examines sleep apnea’s role in lung diseases

Apr. 13, 2012—Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more